{"id":110777,"date":"2024-07-11T00:00:00","date_gmt":"2024-07-11T00:00:00","guid":{"rendered":"https:\/\/medgoo.com\/index.php\/2024\/07\/11\/new-research-points-towards-potential-treatment-for-anorexia\/"},"modified":"2024-07-11T00:00:00","modified_gmt":"2024-07-11T00:00:00","slug":"new-research-points-towards-potential-treatment-for-anorexia","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2024\/07\/11\/new-research-points-towards-potential-treatment-for-anorexia\/","title":{"rendered":"New Research Points Towards Potential Treatment for Anorexia"},"content":{"rendered":"<h3><\/h3>\n<p><b>By Dennis Thompson HealthDay Reporter<\/b><\/p>\n<p><b><\/b><\/p>\n<p>THURSDAY, July 11, 2024 (HealthDay News) &#8212; Anorexia nervosa could be caused by lack of a specific brain chemical, reports a research team that has developed a possible cure for the <a href=\"https:\/\/www.healthday.com\/health-news\/neurology\/teens-with-epilepsy-face-higher-odds-for-eating-disorders\">eating disorder<\/a>.<\/p>\n<p>Mouse studies have revealed that a deficit in acetylcholine, a neurotransmitter associated with the brain&#8217;s reward system, could be linked to excessive habit formation.<\/p>\n<p>This deficit could be behind the compulsive self-starvation seen in people with anorexia, researchers argue in the July 7 issue of the journal <em><a href=\"https:\/\/www.nature.com\/articles\/s41467-024-49371-1\">Nature Communications<\/a><\/em>.<\/p>\n<p>The Alzheimer&#8217;s drug <a href=\"https:\/\/www.drugs.com\/donepezil.html\">donepezil<\/a>, which increases acetylcholine, fully reversed the anorexia-like behavior in mice, and we believe that it could potentially offer the first mechanism-based treatment of anorexia nervosa, said senior researcher <a href=\"https:\/\/douglas.research.mcgill.ca\/salah-el-mestikawy\">Dr. Salah El Mestikawy<\/a>, professor of psychiatry with McGill University&#8217;s Douglas Research Center in Montreal.<\/p>\n<p>In fact, we are already seeing its effects on some patients with the disease, El Mestikawy added in a McGill news release.<\/p>\n<p>Positive results have already been seen in 10 patients with severe anorexia who are being treated with low doses of donepezil, researchers said.<\/p>\n<p>Three patients are in full remission from anorexia, and the other seven have shown marked improvements, results show.<\/p>\n<p>Full-fledged clinical trials comparing donepezil against placebo in treating anorexia are set to start later this year at three major hospitals in the United States and France, researchers said.<\/p>\n<p>However, El Mestikawy cautioned that it could take several years before a new drug targeting anorexia receives government approval and becomes available to patients.<\/p>\n<p>Donepezil causes many gastrointestinal and muscle side effects, El Mestikawy said. Researchers are working to develop a new drug that boosts acetylcholine with fewer problems.<\/p>\n<p>We also suspect that other compulsive pathologies such as obsessive-compulsive disorders (OCD) and addictions can also be improved by donepezil, so we are actively looking for collaboration with other psychiatrist[s] around the world to explore the possibilities, El Mestikawy added.<\/p>\n<p><strong>More information<\/strong><\/p>\n<p>Johns Hopkins Medicine has more on <a href=\"https:\/\/www.hopkinsmedicine.org\/health\/conditions-and-diseases\/eating-disorders\/anorexia-nervosa\">anorexia<\/a>.<\/p>\n<p>SOURCE: McGill University, news release, July 7, 2024<\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2024 <a href=\"https:\/\/consumer.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>By Dennis Thompson HealthDay Reporter THURSDAY, July 11, 2024 (HealthDay News) &#8212; Anorexia nervosa could be caused by lack of a specific brain chemical, reports a research team that has developed a possible cure for the eating disorder. Mouse studies have revealed that a deficit in acetylcholine, a neurotransmitter associated with the brain&#8217;s reward system, [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":110778,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-110777","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/110777","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=110777"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/110777\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/110778"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=110777"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=110777"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=110777"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}